CHICAGO — The American Epilepsy Society (AES) is pleased to recognize Peter B. Crino, MD, PhD, as the 2026 Lombroso Lecturer, honoring his contributions to epilepsy research, particularly his investigations into developmental brain disorders and the biological mechanisms underlying epilepsy.
Dr. Crino is the Dr. Richard and Kathryn Taylor Endowed Professor and Chair of Neurology at the University of Maryland School of Medicine. He directs the Clinical Center for Adults with Neuro-Developmental Disabilities and the university's nationally recognized Tuberous Sclerosis Complex Center of Excellence.
For more than three decades, Dr. Crino has maintained a translational research program investigating developmental brain malformations associated with epilepsy, autism, and intellectual disabilities that has been continuously funded by the National Institutes of Health. His work has advanced scientific understanding of these complex conditions and contributed to the broader pursuit of targeted therapeutic approaches.
Dr. Crino has authored more than 200 scientific publications, reviews, and book chapters. His research and leadership have earned numerous honors, including the NINDS Jacob Javits Neuroscience Investigator Award, the Tuberous Sclerosis Alliance Lifetime Service Award, and he was the inaugural recipient of the AES Fritz E. Dreifuss Award for Translational Research in Epilepsy in 2016.
An active contributor to the epilepsy professional community, Dr. Crino has held numerous AES leadership roles, including Scientific Program Chair for the Annual Meeting and co-chair of the Research and Training Council. Dr. Crino has also served on the AES Investigator's Workshop Committee, the Anti-Epileptic Therapy Symposium Committee, and he directed the AES TSC Special Interest Group. He has also served as chair of the Board of Directors of the Tuberous Sclerosis Alliance.
His selection as the 2026 Lombroso Lecturer recognizes a career dedicated to connecting fundamental neuroscience discoveries with clinical understanding and care for people affected by epilepsy and neurodevelopmental disorders.